![Anne-Kathrin Stoller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anne-Kathrin Stoller
Corporate Officer/Principal bei BACHEM HOLDING AG
Profil
Anne-Kathrin Stoller is currently the Chief Operating Officer-Bachem America at Bachem Holding AG since 2022.
She is also a Member-Supervisory Board at Bachem AG since 2006.
Previously, she held the position of Vice President-Marketing & Sales at Bachem AG from 2008 to 2010.
Dr. Stoller obtained a doctorate degree from the University of Basel.
Aktuelle Nachrichten zu Anne-Kathrin Stoller
| Bachem : AR22 d web | 28.02.23 | PU |
| Morning Briefing - Markt Schweiz | 07.01.22 | AW |
| Bachem Marketingchef wird zum neu geschaffenen COO für Amerika ernannt | 07.01.22 | MT |
| Bachem bekommt neuen Marketingchef | 06.01.22 | AW |
| Bachem ernennt Anne-Kathrin Stoller zum Chief Marketing Officer | 01.09.17 | AW |
Aktive Positionen von Anne-Kathrin Stoller
| Unternehmen | Position | Beginn |
|---|---|---|
| BACHEM HOLDING AG | Corporate Officer/Principal | 01.03.2022 |
Bachem AG
 Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Direktor/Vorstandsmitglied | 01.01.2006 |
Ehemalige bekannte Positionen von Anne-Kathrin Stoller
| Unternehmen | Position | Ende |
|---|---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Vertrieb & Marketing | 01.01.2010 |
Ausbildung von Anne-Kathrin Stoller
| University of Basel | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BACHEM HOLDING AG | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
